Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US MANAMA, Kingdom of Bahrain, Feb ...
The global Gene Editing Market was valued at $5.1 billion in 2022 and is projected to reach $16.2 billion by 2030, growing at ...
The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...
An SCD patient in Bahrain received the gene-editing therapy Casgevy, marking the first time the treatment has been given outside the U.S.
The Mater Hospital has successfully treated the first patient in Ireland with a ground-breaking ocular gene therapy. The gene ...
News Medical on MSN14h
Using CRISPR to remove extra chromosomes in Down syndromeGene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...
Most mutations that decreased antibiotic susceptibility were related to specific metabolic pathways. A MIC-increase to ...
News Medical on MSN21h
Gene therapy breakthrough offers hope for severe Dravet syndrome casesAAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...
A new discovery offers hope for Huntington’s disease. This discovery provides hope that a DNA repair process may help slow or ...
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback